NiPT is not a substitute of PGTA, but a screening tool to select the best embryos. Together with the latest generation ...

Listening to the community's needs, the Sickle Cell Consortium also created the Caregiver Summit, offering a vital space for ...

Clifton Kirkman, a brave warrior in the fight against sickle cell, was born before Michigan's sickle cell mandate, leading to ...

Martin Mwita, 20, is the first patient in St. Louis and among the first across the country to receive a new gene therapy for ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with sickle cell disease ... a concept known as genetic polymorphism.

Anesthesia Center for Critical Care Research, Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, United ...

Period-driven inflammation could influence the risk of pain events among women with sickle cell disease Levels of C-reactive protein increase among women with sickle cell disease during the first ...

The study provides a comprehensive behavioral dataset of Drosophila melanogaster, categorized by genetic background, sex, and social context (isolated or in groups). Beyond enabling detailed ...

DEAR DR. ROACH: I was recently at the American Red Cross to donate blood and was given interesting material on the need for Black blood donors for sickle cell anemia patients. The booklet ...

The CDC’s Division of Blood Disorders ran the Sickle Cell Data Collection program, which assessed the long-term trends of treatment and access to health care for people living with sickle cell ...

Bluebird Bio and Xcellbio have entered into an agreement to support the commercialization of Lyfgenia (lovotibeglogene autotemcel), Bluebird’s gene therapy for sickle cell disease, incorporating ...

Dr. Vinay Nandicoori, Director of CSIR-CCMB, elaborated on the institute’s accomplishments in molecular biology, genetic diagnostics ... s most impactful initiatives has been its work on sickle cell ...